Literature DB >> 25234295

Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core-needle biopsies: a double-centre study.

Shona Kalkman1, Joris P Bulte, Altuna Halilovic, Peter Bult, Paul J van Diest.   

Abstract

AIMS: Immunohistochemical assessment of Ki67 expression in core-needle biopsies (CNBs) is increasingly playing a role in therapeutic decision-making for breast cancer patients. Within the framework of same-day diagnosis of breast lesions, fixation times are markedly decreased. We therefore attempted to validate Ki67 analysis in briefly fixed breast cancer CNBs. METHODS AND
RESULTS: CNBs of 136 consecutive patients with invasive breast cancer diagnosed through the same-day diagnosis programme of both the University Medical Centre Utrecht (UMCU) and the Radboud University Medical Centre (RUMC) were included. CNBs were fixed in formaldehyde for approximately 45 min at the UMCU and for between 60 and 90 min at the RUMC. Immunohistochemistry for Ki67 expression was compared between the briefly fixed CNBs and conventionally fixed resection specimens of the same tumour. The overall agreement between CNBs and resections was 122 of 142 (85.9%) (κ = 0.71; 95% CI 0.60-0.83). Positive and negative predictive values were 79.7% (95% CI 67-88%) and 91.0% (95% CI 82-96%), respectively.
CONCLUSIONS: Overall agreement for Ki67 expression was good between briefly fixed CNBs and conventionally fixed resection specimens, and within the range of studies comparing conventionally fixed CNBs and resections.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Ki67; breast cancer; cell proliferation; core-needle biopsy; fixation time; immunohistochemistry

Mesh:

Substances:

Year:  2014        PMID: 25234295     DOI: 10.1111/his.12521

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  2 in total

1.  Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens.

Authors:  Joris P Bulte; Altuna Halilovic; Lambert J M Burgers; Coos J M Diepenbroek; Robin A K de la Roij; Ritse M Mann; Marloes van der Leest; Patricia H J van Cleef; Luc J A Strobbe; Johannes H W de Wilt; Peter Bult
Journal:  Am J Clin Pathol       Date:  2020-01-01       Impact factor: 2.493

2.  Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.

Authors:  Balazs Acs; Samuel C Y Leung; Kelley M Kidwell; Indu Arun; Renaldas Augulis; Sunil S Badve; Yalai Bai; Anita L Bane; John M S Bartlett; Jane Bayani; Gilbert Bigras; Annika Blank; Henk Buikema; Martin C Chang; Robin L Dietz; Andrew Dodson; Susan Fineberg; Cornelia M Focke; Dongxia Gao; Allen M Gown; Carolina Gutierrez; Johan Hartman; Zuzana Kos; Anne-Vibeke Lænkholm; Arvydas Laurinavicius; Richard M Levenson; Rustin Mahboubi-Ardakani; Mauro G Mastropasqua; Sharon Nofech-Mozes; C Kent Osborne; Frédérique M Penault-Llorca; Tammy Piper; Mary Anne Quintayo; Tilman T Rau; Stefan Reinhard; Stephanie Robertson; Roberto Salgado; Tomoharu Sugie; Bert van der Vegt; Giuseppe Viale; Lila A Zabaglo; Daniel F Hayes; Mitch Dowsett; Torsten O Nielsen; David L Rimm
Journal:  Mod Pathol       Date:  2022-06-21       Impact factor: 8.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.